Kamada

Kamada is a biopharmaceutical company developing, producing and marketing a line of specialty, life-saving therapeutics using its proprietary chromatographic purification technology. Licensed and marketed in more than 15 countries, several of these specialty therapeutics hold registered and pending patents and are currently in advanced clinical trials.

Kamada Announces That It Had Successfully Met the Primary Endpoint in Its US Phase III Clinical Trial with Intravenous AAT (Globes/Hebrew)

Corporate Landmarks Video
Two decades of corporate landmarks

Company Video

Technology

Kamada's proprietary protein purification technology enables us to produce almost any required specific immunoglobulin in addition to other niche products of a similar nature. Kamada's advanced technology enables it to manufacture high quality products to high purity levels. Read More

Investor Relations

	Corporate Overview

Corporate Overview

	Stock Information

Financial Reports

	Management

Board of Directors

	Press Releases

Events

	Press Kit

Email Alerts

	Pharmaceutical Glossary

IR Contact

News & Events

April 9, 2008

Kamada Receives a European Patent for its AAT Manufacturing Process

April 8, 2008

Kamada was Granted New Orphan Drug Designation by the FDA, for its Aerosolized AAT for the treatment of Bronchiectasis

Terms and Conditions | Privacy Policy | Colours